Goldman Sachs’s PRA Health Sciences, Inc. PRAH Stock Holding History

Goldman Sachs’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50,000	Closed	-$3.81M	–	6789
2017 Q3	$3.81M	Sell	50,000 -100,000	-67%	-$7.56M	﹤0.01%	3409
2017 Q2	$11.3M	Hold	150,000	–	–	﹤0.01%	2420
2017 Q1	$9.79M	Buy	+150,000	New	+$8.83M	﹤0.01%	2429
2016 Q3	–	Sell	-15,000	Closed	-$626K	–	7258
2016 Q2	$626K	Buy	+15,000	New	+$691K	﹤0.01%	4638

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Goldman Sachs's PRAH Position: Q3 2021 in Review

Goldman Sachs sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,346,352 shares — an estimated $222M sold.

Goldman Sachs first reported a position in PRAH in Q1 2015 and held it in 25 quarters. The position peaked at $222M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Goldman Sachs reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Goldman Sachs sold 1,346,352 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $222M.
Goldman Sachs first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 25 quarters.
Goldman Sachs's PRA Health Sciences, Inc. position peaked at $222M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.